Chronic Myeloid Leukemia (CML) Treatment Market - Global Outlook and Forecast 2022-2028
Chronic myeloid leukaemia (CML) is a type cancer that affects the blood and bone marrow.
This report contains market size and forecasts of Chronic Myeloid Leukemia (CML) Treatment in Global, including the following market information:
Global Chronic Myeloid Leukemia (CML) Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Chronic Myeloid Leukemia (CML) Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Targeted Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chronic Myeloid Leukemia (CML) Treatment include Novartis AG, Bristol-Myers Squibb, Teva Pharmaceuticals Industries Ltd., ARIAD Pharmaceuticals, Inc., Pfizer, Inc., Hospira, Inc., Prism Pharmaceuticals, Incyte Corporation and Bio-Path Holdings, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Myeloid Leukemia (CML) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Myeloid Leukemia (CML) Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Chronic Myeloid Leukemia (CML) Treatment Market Segment Percentages, by Type, 2021 (%)
Global Chronic Myeloid Leukemia (CML) Treatment Market Segment Percentages, by Application, 2021 (%)
Global Chronic Myeloid Leukemia (CML) Treatment Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Chronic Myeloid Leukemia (CML) Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Chronic Myeloid Leukemia (CML) Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Chronic Myeloid Leukemia (CML) Treatment in Global, including the following market information:
Global Chronic Myeloid Leukemia (CML) Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Chronic Myeloid Leukemia (CML) Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Targeted Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chronic Myeloid Leukemia (CML) Treatment include Novartis AG, Bristol-Myers Squibb, Teva Pharmaceuticals Industries Ltd., ARIAD Pharmaceuticals, Inc., Pfizer, Inc., Hospira, Inc., Prism Pharmaceuticals, Incyte Corporation and Bio-Path Holdings, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Myeloid Leukemia (CML) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Myeloid Leukemia (CML) Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Chronic Myeloid Leukemia (CML) Treatment Market Segment Percentages, by Type, 2021 (%)
- Targeted Therapy
- Chemotherapy
- Radiation Therapy
- Splenectomy
- Stem Cell Transplant
Global Chronic Myeloid Leukemia (CML) Treatment Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinic
- Others
Global Chronic Myeloid Leukemia (CML) Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Chronic Myeloid Leukemia (CML) Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Chronic Myeloid Leukemia (CML) Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novartis AG
- Bristol-Myers Squibb
- Teva Pharmaceuticals Industries Ltd.
- ARIAD Pharmaceuticals, Inc.
- Pfizer, Inc.
- Hospira, Inc.
- Prism Pharmaceuticals
- Incyte Corporation
- Bio-Path Holdings
- Stragen Pharma SA
- Otsuka Pharmaceutical Co., Ltd.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Chronic Myeloid Leukemia (CML) Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Myeloid Leukemia (CML) Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CHRONIC MYELOID LEUKEMIA (CML) TREATMENT OVERALL MARKET SIZE
2.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Size: 2021 VS 2028
2.2 Global Chronic Myeloid Leukemia (CML) Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Chronic Myeloid Leukemia (CML) Treatment Players in Global Market
3.2 Top Global Chronic Myeloid Leukemia (CML) Treatment Companies Ranked by Revenue
3.3 Global Chronic Myeloid Leukemia (CML) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Chronic Myeloid Leukemia (CML) Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Chronic Myeloid Leukemia (CML) Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chronic Myeloid Leukemia (CML) Treatment Players in Global Market
3.6.1 List of Global Tier 1 Chronic Myeloid Leukemia (CML) Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Chronic Myeloid Leukemia (CML) Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Chronic Myeloid Leukemia (CML) Treatment Market Size Markets, 2021 & 2028
4.1.2 Targeted Therapy
4.1.3 Chemotherapy
4.1.4 Radiation Therapy
4.1.5 Splenectomy
4.1.6 Stem Cell Transplant
4.2 By Type - Global Chronic Myeloid Leukemia (CML) Treatment Revenue & Forecasts
4.2.1 By Type - Global Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2022
4.2.2 By Type - Global Chronic Myeloid Leukemia (CML) Treatment Revenue, 2023-2028
4.2.3 By Type - Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Chronic Myeloid Leukemia (CML) Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Chronic Myeloid Leukemia (CML) Treatment Revenue & Forecasts
5.2.1 By Application - Global Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2022
5.2.2 By Application - Global Chronic Myeloid Leukemia (CML) Treatment Revenue, 2023-2028
5.2.3 By Application - Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Chronic Myeloid Leukemia (CML) Treatment Market Size, 2021 & 2028
6.2 By Region - Global Chronic Myeloid Leukemia (CML) Treatment Revenue & Forecasts
6.2.1 By Region - Global Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2022
6.2.2 By Region - Global Chronic Myeloid Leukemia (CML) Treatment Revenue, 2023-2028
6.2.3 By Region - Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2028
6.3.2 US Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.3.3 Canada Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.3.4 Mexico Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2028
6.4.2 Germany Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.4.3 France Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.4.4 U.K. Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.4.5 Italy Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.4.6 Russia Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.4.8 Benelux Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2028
6.5.2 China Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.5.3 Japan Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.5.4 South Korea Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.5.6 India Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2028
6.6.2 Brazil Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.6.3 Argentina Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2028
6.7.2 Turkey Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.7.3 Israel Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.7.5 UAE Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Novartis AG
7.1.1 Novartis AG Corporate Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.1.4 Novartis AG Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.1.5 Novartis AG Key News
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Corporate Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.2.4 Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.2.5 Bristol-Myers Squibb Key News
7.3 Teva Pharmaceuticals Industries Ltd.
7.3.1 Teva Pharmaceuticals Industries Ltd. Corporate Summary
7.3.2 Teva Pharmaceuticals Industries Ltd. Business Overview
7.3.3 Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.3.4 Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.3.5 Teva Pharmaceuticals Industries Ltd. Key News
7.4 ARIAD Pharmaceuticals, Inc.
7.4.1 ARIAD Pharmaceuticals, Inc. Corporate Summary
7.4.2 ARIAD Pharmaceuticals, Inc. Business Overview
7.4.3 ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.4.4 ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.4.5 ARIAD Pharmaceuticals, Inc. Key News
7.5 Pfizer, Inc.
7.5.1 Pfizer, Inc. Corporate Summary
7.5.2 Pfizer, Inc. Business Overview
7.5.3 Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.5.4 Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.5.5 Pfizer, Inc. Key News
7.6 Hospira, Inc.
7.6.1 Hospira, Inc. Corporate Summary
7.6.2 Hospira, Inc. Business Overview
7.6.3 Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.6.4 Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.6.5 Hospira, Inc. Key News
7.7 Prism Pharmaceuticals
7.7.1 Prism Pharmaceuticals Corporate Summary
7.7.2 Prism Pharmaceuticals Business Overview
7.7.3 Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.7.4 Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.7.5 Prism Pharmaceuticals Key News
7.8 Incyte Corporation
7.8.1 Incyte Corporation Corporate Summary
7.8.2 Incyte Corporation Business Overview
7.8.3 Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.8.4 Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.8.5 Incyte Corporation Key News
7.9 Bio-Path Holdings
7.9.1 Bio-Path Holdings Corporate Summary
7.9.2 Bio-Path Holdings Business Overview
7.9.3 Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.9.4 Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.9.5 Bio-Path Holdings Key News
7.10 Stragen Pharma SA
7.10.1 Stragen Pharma SA Corporate Summary
7.10.2 Stragen Pharma SA Business Overview
7.10.3 Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.10.4 Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.10.5 Stragen Pharma SA Key News
7.11 Otsuka Pharmaceutical Co., Ltd.
7.11.1 Otsuka Pharmaceutical Co., Ltd. Corporate Summary
7.11.2 Otsuka Pharmaceutical Co., Ltd. Business Overview
7.11.3 Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.11.4 Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.11.5 Otsuka Pharmaceutical Co., Ltd. Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Chronic Myeloid Leukemia (CML) Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Myeloid Leukemia (CML) Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CHRONIC MYELOID LEUKEMIA (CML) TREATMENT OVERALL MARKET SIZE
2.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Size: 2021 VS 2028
2.2 Global Chronic Myeloid Leukemia (CML) Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Chronic Myeloid Leukemia (CML) Treatment Players in Global Market
3.2 Top Global Chronic Myeloid Leukemia (CML) Treatment Companies Ranked by Revenue
3.3 Global Chronic Myeloid Leukemia (CML) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Chronic Myeloid Leukemia (CML) Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Chronic Myeloid Leukemia (CML) Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chronic Myeloid Leukemia (CML) Treatment Players in Global Market
3.6.1 List of Global Tier 1 Chronic Myeloid Leukemia (CML) Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Chronic Myeloid Leukemia (CML) Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Chronic Myeloid Leukemia (CML) Treatment Market Size Markets, 2021 & 2028
4.1.2 Targeted Therapy
4.1.3 Chemotherapy
4.1.4 Radiation Therapy
4.1.5 Splenectomy
4.1.6 Stem Cell Transplant
4.2 By Type - Global Chronic Myeloid Leukemia (CML) Treatment Revenue & Forecasts
4.2.1 By Type - Global Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2022
4.2.2 By Type - Global Chronic Myeloid Leukemia (CML) Treatment Revenue, 2023-2028
4.2.3 By Type - Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Chronic Myeloid Leukemia (CML) Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Chronic Myeloid Leukemia (CML) Treatment Revenue & Forecasts
5.2.1 By Application - Global Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2022
5.2.2 By Application - Global Chronic Myeloid Leukemia (CML) Treatment Revenue, 2023-2028
5.2.3 By Application - Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Chronic Myeloid Leukemia (CML) Treatment Market Size, 2021 & 2028
6.2 By Region - Global Chronic Myeloid Leukemia (CML) Treatment Revenue & Forecasts
6.2.1 By Region - Global Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2022
6.2.2 By Region - Global Chronic Myeloid Leukemia (CML) Treatment Revenue, 2023-2028
6.2.3 By Region - Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2028
6.3.2 US Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.3.3 Canada Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.3.4 Mexico Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2028
6.4.2 Germany Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.4.3 France Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.4.4 U.K. Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.4.5 Italy Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.4.6 Russia Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.4.8 Benelux Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2028
6.5.2 China Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.5.3 Japan Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.5.4 South Korea Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.5.6 India Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2028
6.6.2 Brazil Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.6.3 Argentina Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2028
6.7.2 Turkey Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.7.3 Israel Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
6.7.5 UAE Chronic Myeloid Leukemia (CML) Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Novartis AG
7.1.1 Novartis AG Corporate Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.1.4 Novartis AG Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.1.5 Novartis AG Key News
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Corporate Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.2.4 Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.2.5 Bristol-Myers Squibb Key News
7.3 Teva Pharmaceuticals Industries Ltd.
7.3.1 Teva Pharmaceuticals Industries Ltd. Corporate Summary
7.3.2 Teva Pharmaceuticals Industries Ltd. Business Overview
7.3.3 Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.3.4 Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.3.5 Teva Pharmaceuticals Industries Ltd. Key News
7.4 ARIAD Pharmaceuticals, Inc.
7.4.1 ARIAD Pharmaceuticals, Inc. Corporate Summary
7.4.2 ARIAD Pharmaceuticals, Inc. Business Overview
7.4.3 ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.4.4 ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.4.5 ARIAD Pharmaceuticals, Inc. Key News
7.5 Pfizer, Inc.
7.5.1 Pfizer, Inc. Corporate Summary
7.5.2 Pfizer, Inc. Business Overview
7.5.3 Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.5.4 Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.5.5 Pfizer, Inc. Key News
7.6 Hospira, Inc.
7.6.1 Hospira, Inc. Corporate Summary
7.6.2 Hospira, Inc. Business Overview
7.6.3 Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.6.4 Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.6.5 Hospira, Inc. Key News
7.7 Prism Pharmaceuticals
7.7.1 Prism Pharmaceuticals Corporate Summary
7.7.2 Prism Pharmaceuticals Business Overview
7.7.3 Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.7.4 Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.7.5 Prism Pharmaceuticals Key News
7.8 Incyte Corporation
7.8.1 Incyte Corporation Corporate Summary
7.8.2 Incyte Corporation Business Overview
7.8.3 Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.8.4 Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.8.5 Incyte Corporation Key News
7.9 Bio-Path Holdings
7.9.1 Bio-Path Holdings Corporate Summary
7.9.2 Bio-Path Holdings Business Overview
7.9.3 Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.9.4 Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.9.5 Bio-Path Holdings Key News
7.10 Stragen Pharma SA
7.10.1 Stragen Pharma SA Corporate Summary
7.10.2 Stragen Pharma SA Business Overview
7.10.3 Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.10.4 Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.10.5 Stragen Pharma SA Key News
7.11 Otsuka Pharmaceutical Co., Ltd.
7.11.1 Otsuka Pharmaceutical Co., Ltd. Corporate Summary
7.11.2 Otsuka Pharmaceutical Co., Ltd. Business Overview
7.11.3 Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Major Product Offerings
7.11.4 Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Revenue in Global Market (2017-2022)
7.11.5 Otsuka Pharmaceutical Co., Ltd. Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Chronic Myeloid Leukemia (CML) Treatment Market Opportunities & Trends in Global Market
Table 2. Chronic Myeloid Leukemia (CML) Treatment Market Drivers in Global Market
Table 3. Chronic Myeloid Leukemia (CML) Treatment Market Restraints in Global Market
Table 4. Key Players of Chronic Myeloid Leukemia (CML) Treatment in Global Market
Table 5. Top Chronic Myeloid Leukemia (CML) Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Chronic Myeloid Leukemia (CML) Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Chronic Myeloid Leukemia (CML) Treatment Product Type
Table 9. List of Global Tier 1 Chronic Myeloid Leukemia (CML) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Myeloid Leukemia (CML) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Chronic Myeloid Leukemia (CML) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Chronic Myeloid Leukemia (CML) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Chronic Myeloid Leukemia (CML) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Chronic Myeloid Leukemia (CML) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 32. Novartis AG Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Corporate Summary
Table 34. Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 35. Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Teva Pharmaceuticals Industries Ltd. Corporate Summary
Table 37. Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 38. Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 39. ARIAD Pharmaceuticals, Inc. Corporate Summary
Table 40. ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 41. ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer, Inc. Corporate Summary
Table 43. Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 44. Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Hospira, Inc. Corporate Summary
Table 46. Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 47. Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Prism Pharmaceuticals Corporate Summary
Table 49. Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 50. Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Incyte Corporation Corporate Summary
Table 52. Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 53. Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Bio-Path Holdings Corporate Summary
Table 55. Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 56. Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Stragen Pharma SA Corporate Summary
Table 58. Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 59. Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Otsuka Pharmaceutical Co., Ltd. Corporate Summary
Table 61. Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 62. Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 1. Chronic Myeloid Leukemia (CML) Treatment Market Opportunities & Trends in Global Market
Table 2. Chronic Myeloid Leukemia (CML) Treatment Market Drivers in Global Market
Table 3. Chronic Myeloid Leukemia (CML) Treatment Market Restraints in Global Market
Table 4. Key Players of Chronic Myeloid Leukemia (CML) Treatment in Global Market
Table 5. Top Chronic Myeloid Leukemia (CML) Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Chronic Myeloid Leukemia (CML) Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Chronic Myeloid Leukemia (CML) Treatment Product Type
Table 9. List of Global Tier 1 Chronic Myeloid Leukemia (CML) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Myeloid Leukemia (CML) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Chronic Myeloid Leukemia (CML) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Chronic Myeloid Leukemia (CML) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Chronic Myeloid Leukemia (CML) Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Chronic Myeloid Leukemia (CML) Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 32. Novartis AG Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Corporate Summary
Table 34. Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 35. Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Teva Pharmaceuticals Industries Ltd. Corporate Summary
Table 37. Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 38. Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 39. ARIAD Pharmaceuticals, Inc. Corporate Summary
Table 40. ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 41. ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer, Inc. Corporate Summary
Table 43. Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 44. Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Hospira, Inc. Corporate Summary
Table 46. Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 47. Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Prism Pharmaceuticals Corporate Summary
Table 49. Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 50. Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Incyte Corporation Corporate Summary
Table 52. Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 53. Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Bio-Path Holdings Corporate Summary
Table 55. Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 56. Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Stragen Pharma SA Corporate Summary
Table 58. Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 59. Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Otsuka Pharmaceutical Co., Ltd. Corporate Summary
Table 61. Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Product Offerings
Table 62. Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Chronic Myeloid Leukemia (CML) Treatment Segment by Type in 2021
Figure 2. Chronic Myeloid Leukemia (CML) Treatment Segment by Application in 2021
Figure 3. Global Chronic Myeloid Leukemia (CML) Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chronic Myeloid Leukemia (CML) Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chronic Myeloid Leukemia (CML) Treatment Revenue in 2021
Figure 8. By Type - Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
Figure 12. US Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
Figure 24. China Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis AG Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Chronic Myeloid Leukemia (CML) Treatment Segment by Type in 2021
Figure 2. Chronic Myeloid Leukemia (CML) Treatment Segment by Application in 2021
Figure 3. Global Chronic Myeloid Leukemia (CML) Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chronic Myeloid Leukemia (CML) Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chronic Myeloid Leukemia (CML) Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chronic Myeloid Leukemia (CML) Treatment Revenue in 2021
Figure 8. By Type - Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
Figure 12. US Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
Figure 24. China Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Chronic Myeloid Leukemia (CML) Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis AG Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
